SGLT-2 inhibitors and GLP-1 receptor agonists in metabolic dysfunction-associated fatty liver disease

Moon, JS; Hong, JH; Jung, YJ; Ferrannini, E; Nauck, MA; Lim, S

Nauck, MA (通讯作者)，Ruhr Univ, Diabet Div, Katholisches Klinikum Bochum, St Josef Hosp, Bochum, Germany.;Lim, S (通讯作者)，Seoul Natl Univ, Dept Internal Med, Coll Med, Seongnam, South Korea.;Lim, S (通讯作者)，Seoul Natl Univ, Bundang Hosp, Seongnam, South Korea.

TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2022; 33 (6): 424

Abstract

Metabolic dysfunction-associated fatty liver disease (MAFLD) is a chronic condition that affects nearly one billion people globally, characterized by ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索